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Introduction
For peripheral pulmonary lesions, conventional ex-
aminations such as sputum analysis, bronchoscopy,
and routine chest radiographs are often limited in
disease diagnosis. Thus, image-guided percutaneous
needle biopsy (using fluoroscopy, computed tomog-
raphy, and ultrasound [US]) has been used to sample
tissues and aid in diagnosis [1–8]. Of these modal-
ities, chest US examination and US-guided needle
biopsy provide the simplest and most rapid and
convenient diagnostic tools for all lesions abutting
the chest wall [5–12]. Chest US examinations have
a number of advantages: they can be performed at
the bedside, in the patient’s most comfortable and
appropriate position (sitting, prone, or supine), and
without exposure to irradiation. In particular, im-
provements in US image resolution and the use of
a well-suited puncture-guiding device have made
US-guided needle biopsy increasingly real-time, safe,
and convenient [5,7,11]. In the literature, chest US
examinations and US-guided needle biopsy have
been shown to be valuable in diagnosing lung can-
cers, mediastinal tumors, pleural lesions, chest wall
lesions, and some peripheral pulmonary infections,
with excellent results and minimal complications
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The wide application of recent advances in chest ultrasound has enabled color Doppler
ultrasound (CDUS) to be used in evaluating thoracic lesions. Clinically, CDUS is helpful 
in assessing vessel signals within the thoracic lesions, differentiating lung cancers from
benign lesions, assessing the neovascularity of lung cancers, diagnosing congenital vascular
abnormalities (pulmonary sequestration and arteriovenous malformation), and avoiding
the complication of US-guided needle biopsy injury to the great vessels. The CDUS “fluid
color sign” can be used to detect minimal pleural effusion in thoracocentesis, and the
CDUS “pulmonary artery vessel signal” is useful in predicting pulmonary benign lesions.
Though CDUS still has some limitations in its capability to image vessel signals, the devel-
opment of power Doppler US (US angiography) has improved images of vessel signals
without angle limitation, and the newly developed dynamic flow US produces superior
imaging quality with less color noise and blooming effect. The broad application and
potential extension of CDUS in thoracic diseases has made CDUS a powerful and necessary
imaging modality in chest medicine, especially in guiding transthoracic percutaneous needle
biopsy of thoracic lesions and aiding in the differentiation of anatomic tissue.
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[5–12]. However, conventional grayscale chest US
alone is somewhat limited in the assessment of
vessel signals in thoracic lesions.
Color Doppler US (CDUS) is used for the evalu-
ation of vessel signals in normal tissues and organs
and in pathologic lesions; it has been widely used
in the cardiovascular system, abdominal lesions, ob-
stetric and gynecologic lesions, breast lesions, and
carotid and intracranial vessels [13–20]. Recently,
CDUS has also been applied in chest medicine. As
reported in the literature and from our own expe-
rience, CDUS not only clearly demonstrates the vessel
signals in thoracic lesions, but also enables assess-
ment of hemodynamic changes, tumor neovascu-
larity, congenital vascular anomalies, and anatomic
tissue differentiation [21–27]. In particular, CDUS and
its color-based puncture-guiding device readily dis-
close the prominent vessels and, therefore, signifi-
cantly increase the safety and clinical extension of
US-guided percutaneous needle biopsy [28,29]. The
development of power Doppler US (PDUS) has fur-
ther improved images of vessel signals without angle
limitation, and the newly developed dynamic flow
US (DFUS) discloses vessel signals with less color
noise and blooming effect [19,20,30,31].
In the present report, we review the published lit-
erature and describe our experience with the clinical
applications of CDUS in chest medicine.
Indications and Technique for Chest 
US and CDUS Examinations
Indications
Chest US is used initially to assess pleural effusion
and pleural opacity [32,33]. However, any pulmo-
nary lesions and mediastinal tumors abutting the
chest wall, pleural lesions, and chest wall lesions are
all suitable for chest US examination [5–12].
In usual clinical practice, a grayscale US exam-
ination is performed initially, after which CDUS
examination can be added to assess vessel signals
within the lesion. In the assessment of pulmonary
consolidations and mediastinal tumors, CDUS readily
demonstrates and evaluates the vessel signals and
can thus help prevent injury to prominent vessels
when performing transthoracic US-guided needle
biopsy [28,29].
In our experience, only a number of special con-
ditions are contraindicated for chest US examination
and US-guided needle biopsy: (1) when the patient
is not cooperative in holding his/her breath while
performing transthoracic US-guided needle biopsy
for peripheral pulmonary lesions; (2) a bleeding ten-
dency with platelets <20,000/mm3; if necessary, the
US-guided needle biopsy can be performed within
12–24 hours after platelet transfusion; (3) recent
myocardial infarction and/or unstable angina; and
(4) lesions poorly demonstrated by US.
Techniques for CDUS examination
In performing a CDUS examination, we still use
grayscale US first to localize the lesions before adding
CDUS. Before the start of the CDUS examination,
the Doppler filter is usually set at 50–100 Hz to elim-
inate low-frequency signals from vessel wall motion
and avoid interference from respiratory and cardiac
movement [13,21,24,34,35]. Color Doppler gain is
also adjusted until only a few noise specks are visible
in the background [14,24]. When the CDUS signal
is detected, the sample volume is re-adjusted to ap-
proximate the size of the detected blood vessels, and
the angle is repositioned to parallel the direction of
blood flow (the Doppler angle θ between the ul-
trasound beam and flow signal is adjusted to obtain
the largest frequency shift or velocity, while remain-
ing below 60° if possible) [14,35]. The pulse repet-
itive frequency is also adjusted, depending on the
blood flow velocity under investigation. Pulse-wave
CDUS is used to detect flow signals within the lesions;
all Doppler signal waveforms are recorded on color-
printed sonopaper and/or on laser disc, thus enabling
all data regarding the CDUS signals and spectral
waveforms of the thoracic lesions to be reviewed
and analyzed. In general, spectral waveforms that are
reproducibly similar over three consecutive cardiac
cycles are recorded as satisfactory [24,36].
CDUS is then used to assess vessel signals within
the lesions, hemodynamic changes (resistive index
[RI] and pulsatility index [PI]), tumor neovascularity,
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any special vascular anomalies, and other tissue
differentiation and clinical applications.
Applications of CDUS in 
Chest Medicine
CDUS has been used for thoracic diseases to evalu-
ate vessel signals within lesions; however, from our
perspective, the clinical applications of CDUS in chest
medicine remain underutilized. The main applica-
tions of CDUS in the published literature and clinical
practice are summarized below.
Correlation of CDUS signals with 
resected histologic specimens
CDUS has been reported as a valuable tool in
assessing the vessel signals of thoracic lesions. Hsu
et al reported their findings on the correlation of
CDUS vessel signals with resected histologic speci-
mens [21]. In their report, they found three vessel
signal flow patterns in lung cancers: pulsatile flow
(artery), triphasic flow (vein), and constant flow (Fig. 1);
only two flow patterns were present in benign
lesions: pulsatile flow and triphasic flow. In correlat-
ing CDUS vessel signals with resected histologic
specimens, constant flow was representative of the
true neovascularity of lung cancers and was valuable
in differentiating lung cancers from benign lesions
(p < 0.001). The correlation between CDUS vessel
signals and resected histologic specimens was also
excellent. Nevertheless, thoracic lesions without
CDUS vessel signals may be completely lacking in
blood vessels or have blood vessels that cannot be
detected by present-day CDUS equipment.
With increasing experience in using CDUS exami-
nations in thoracic lesions, we recently found some
pulmonary veins (often in the collapsed lung and distal
to a central endobronchial tumor) that could present
with constant flows. Thus, we should be careful in the
interpretation of CDUS constant flow vessel signals
within collapsed lungs and in some benign lesions.
CDUS pulsatile flow in the assessment of 
lung cancers and benign lesions
CDUS pulsatile flows have been used to assess and
differentiate malignancies from benign tumors, 
including breast, ovary, kidney, and other organ
Color Doppler Ultrasound in Chest Medicine
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Fig. 1. Three flow patterns of color Doppler ultrasound signals
in thoracic lesions: (A) pulsatile flow, (B) constant flow, and
(C) triphasic flow.
tumors [13–16,34–36]. In the assessment of pulsatile
flows, two parameters are often used: RI (calculated
as peak systolic velocity − end diastolic velocity/peak
systolic velocity), and PI (calculated as peak systolic
velocity − end diastolic velocity/mean velocity). Be-
cause malignancies often have sinusoid-like or large
capillary-like tumor vessels and even arteriovenous
shunts, malignancies are reported to have statistically
significantly lower RI and PI values than benign
lesions [13,14,16,34–36].
Yuan et al first reported the application of CDUS
pulsatile flows in the assessment of thoracic lesions.
In their report, RI and PI values were significant in dif-
ferentiating lung cancers from benign lesions (both
p < 0.01) [24]. However, in our experience, overlap-
ping RI and PI values between lung cancers and
benign lesions are common, thereby limiting the
application of RI and PI values in differentiating lung
cancers from benign lesions [27,37]. An interesting
finding in our series was the lower RI and PI values
in small cell lung cancers when compared with those
in non-small cell lung cancers (adenocarcinoma and
squamous cell carcinoma). The lower RI and PI values
in small cell lung cancers may imply an increasing
and intense downstream angiogenesis; conversely,
the relatively high RI and PI values in non-small cell
lung cancers probably indicate sparse angiogenesis.
Thus, compared with the clinical presentations and
biologic behavior of lung cancers, small cell lung can-
cer with intense angiogenesis has a greater range of
clinical presentations than non-small cell lung cancer;
these presentations include rapid tumor growth,
early metastasis, and sensitivity to chemotherapy.
Further study is warranted to determine whether
CDUS pulsatile flow is helpful in differentiating lung
cancers from benign lesions.
CDUS “Pulmonary Artery Vessel Signal”: 
A Sign for Predicting Benign Lesions
Lung cancers are always supplied by the bronchial
artery system; thus, pulmonary and bronchial angio-
grams were previously used to diagnose and differ-
entiate lung cancers from benign lesions. If vessel
signals within pulmonary lesions can be confirmed
to be those of the pulmonary artery, CDUS should
be able to predict and differentiate benign lesions
from lung cancers (Fig. 2).
We previously arbitrarily defined a CDUS “pul-
monary artery vessel signal” as a pulsatile flow with
a vessel signal length of ≥ 1 cm that is demonstrated
smoothly by CDUS [38]. Using this CDUS vessel sig-
nal, thoracic lesions with at least a detectable CDUS
“pulmonary artery vessel signal” were considered to
be benign. In a study lasting more than 6 years, we
screened and analyzed 264 thoracic lesions (125
lung cancers and 139 benign lesions) and found that
the CDUS “pulmonary artery vessel signal” was reli-
able in predicting and differentiating benign lesions
from lung cancers (p < 0.0001; sensitivity, 0.53 [74/
139]; specificity, 0.98 [123/125]; positive likelihood
ratio, 26.5) (Figs. 3 and 4). Only two specific alveolar
cell carcinomas with lobar consolidation presented
with a CDUS “pulmonary artery vessel signal”; these
were the only exceptions among the lung cancers.
Our results suggest that the CDUS “pulmonary artery
vessel signal” deserves a wide clinical application in
predicting benign pulmonary lesions [38].
CDUS “Fluid Color Sign” to Assess the
Thoracocentesis of Minimal Pleural Effusion
Chest US can be used to assess minimal pleural effu-
sion and guide thoracocentesis. However, CDUS can
be more useful than grayscale US in predicting the
success of thoracocentesis of minimal pleural effu-
sion. Respiratory movement will cause the minimal
pleural effusion to move and create a color signal
under CDUS. Wu et al reported this finding as 
a CDUS “fluid color sign” and proved it to be more
sensitive than grayscale US in predicting the success
of thoracocentesis (Fig. 5) [23,25].
Loculated pleural effusion, however, will not pres-
ent with a CDUS “fluid color sign,” even if it can
be aspirated smoothly. Therefore, the CDUS “fluid
color sign” is not present and cannot be applied to
localized and loculated pleural effusions.
Diagnosis of Specific Vascular Anomalies 
and Utility for Tissue Differentiation
Pulmonary sequestration is a congenital malfor-
mation with non-functioning lung tissue that is
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supplied by an aberrant systemic artery. Hernanz-
Schulman et al reported that CDUS can demonstrate the
aberrant systemic artery supplying the abnormal lung
tissue, and then diagnose pulmonary sequestration
smoothly [26]. In our limited experience, the aber-
rant systemic artery that supplies the pulmonary
sequestration is sometimes easily found by CDUS,
but this task generally proves difficult (Fig. 6).
Color Doppler Ultrasound in Chest Medicine
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Fig. 2. (A) Chest radiograph shows a mass in the left upper lobe. Squamous cell carcinoma was diagnosed by ultrasound-guided
fine-needle aspiration. (B) Bronchial arteriogram shows that the tumor was supplied by the bronchial arteries, originating from the
same level as the right bronchial artery. However, the vessels within the tumor were torturous, small, and irregular (without pre-
dictable direction). (C) Color Doppler ultrasound demonstrated only a small short segment of pulsatile flows within the tumor. (D)
Pulmonary angiogram shows the pulmonary arteries running smoothly and regularly.
A B
Fig. 3. (A) Chest radiography shows a mass-like lesion in the right middle lung field. (B) Color Doppler ultrasound reveals pulsatile flow
within the lesion with the “pulmonary artery vessel signal” present. The pulmonary lesion completely resolved after antibiotic treatment.
Pulmonary arteriovenous malformation is occa-
sionally encountered by chest physicians. Chest
radiograph, computed tomography, and pulmonary
angiography are all valuable in this regard and pro-
vide the potential to detect vascular malformation.
However, CDUS provides a real-time, noninvasive and
convenient imaging modality in rapidly diagnosing
pulmonary arteriovenous malformation (Fig. 7) [22].
For specific vascular lesions, CDUS undoubtedly
has a more powerful imaging function and greater
W.H. Hsu
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Fig. 4. (A) Chest radiograph shows fibroproductive infiltrations
in the bilateral upper lung fields, and active pulmonary tubercu-
losis was considered. (B) After a 1-month chemotherapy for tuber-
culosis, the chest radiograph shows a large mass with cavitation
in the left upper lobe. (C) Thoracic computed tomography also
clearly demonstrates central necrosis in the mass lesion. Clinically,
lung cancer was highly suspected. (D) Grayscale ultrasound also
reveals a well-defined mass-like lesion at the left upper lobe. (E)
However, power Doppler ultrasound could easily demonstrate
the prominent vessels with the “pulmonary artery vessel signal,”
using waveform analysis. After continuing chemotherapy for
tuberculosis for 6 months, the patient’s condition improved, with
only residual lesions on his follow-up chest radiograph.
potential than grayscale US in assessing and diag-
nosing vascular anomalies (Figs. 6 and 7). In some
specific uncommon thoracic lesions, CDUS can
diagnose the underlying diseases and differentiate
the tissue characteristics solely on the basis of
information from its imaging vessel signals (Fig. 8).
CDUS Equipped with a Color-based 
Puncture-guiding Device
Though CDUS can readily demonstrate vessel signals
within lesions, CDUS equipped with a color-based
puncture-guiding device is useful in guiding nee-
dle biopsy, especially in cases of pulmonary consoli-
dation and mediastinal tumors (Fig. 9). Wang et al
compared grayscale US-guided needle biopsy with
CDUS-guided needle biopsy [28] and found that
the diagnostic results and associated complications
were similar; however, visualization of blood vessels
was more common with CDUS than grayscale US 
(p < 0.05). Clinically, CDUS equipped with a color-
based puncture-guiding device can easily demon-
strate the prominent vessels and confidently guide
transthoracic needle biopsy [28,29].
PDUS in the Detection of Vessel Signals
Conventional CDUS has a number of limitations in
assessing vessel signals in thoracic lesions, including
the insonating angle, flow velocity, US probe, anat-
omic narrowing interface, and the necessity of 
patient cooperation. Of these, the limitations in
Color Doppler Ultrasound in Chest Medicine
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Fig. 5. Color Doppler ultrasound “fluid color sign” is present
in a patient with left pleural effusion, which indicates that tho-
racocentesis should be successful.
Fig. 6. Color Doppler ultrasound shows the aberrant systemic
artery originating from the aorta (arrow) and supplying the
consolidated lung.
Fig. 7. (A) Grayscale ultrasound only shows a large anechoic lesion. (B) Color Doppler ultrasound reveals turbulent vessel signal
within the lesion; a large pulmonary arteriovenous malformation was confirmed.
detecting vessels with slow flow and the influence
of the insonating angle are the main concerns in
CDUS [17].
PDUS (or US angiography) has overcome some
of the main limitations of CDUS, especially the influ-
ence of the insonating angle. In the literature,
PDUS is reported to be angle-independent, more
sensitive in detecting vessels with slow flow, and
have less aliasing [19,20]. In our experience, PDUS
is commonly more sensitive in the detection and
illustration of vessel signals than conventional CDUS
(Fig. 10). Nevertheless, the clinical application of
PDUS in chest medicine requires further study.
DFUS in the Illustration of Vessel Signals
CDUS and PDUS can readily produce blooming
effects of vessels and color noise in demonstrating
lesions that abut pulsatile organs [17,25]. The bloom-
ing effect of vessels renders the US assessment of
vessel signals less real, and color noise lowers con-
fidence in the US demonstration of vessel signals.
For vessel signals in thoracic lesions, both CDUS and
PDUS often produce more prominent blooming
effects and color noises because of the respiratory
movement of the lung, diaphragm, and pulsatile or-
gans within the thorax. Therefore, the use of CDUS
and PDUS in the assessment of vessel signals in
thoracic lesions is always difficult.
DFUS is a newly developed color Doppler im-
aging method reported to provide better B-mode
imaging with fewer blooming effects and color
noises, compared with those of conventional CDUS
and PDUS [30,31,39,40]. Clinically, we have used
DFUS, CDUS, and PDUS to evaluate the vessel signals
in 34 thoracic lesions abutting pulsatile organs and
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Fig. 8. (A) Grayscale ultrasound only discloses a typical complex-septated pleural effusion. (B) Color Doppler ultrasound (CDUS)
demonstrates venous flows within the septa; tumor with central necrosis was suspected. (C) Computed tomography confirmed the
diagnosis to be the same as the CDUS findings.
Fig. 9. The color Doppler ultrasound puncture device has the
advantages of adjusted angle selection for needle biopsy, and
detects the prominent vessels easily, thereby preventing the
possible complication of injury to the great vessels.
compared the imaging quality of the vessel signals
in different US modes. Our preliminary results
showed that DFUS, CDUS, and PDUS could all
demonstrate the vessel signals clearly (all p > 0.05).
However, when focusing on the blooming effect
and color noise, DFUS showed superior imaging
quality to CDUS and PDUS (all p≤0.001) (Fig. 11).
In the assessment of decision making for percuta-
neous needle biopsy in particular, DFUS had less
influence than CDUS and PDUS (both p < 0.01) [41].
Therefore, DFUS clearly has a superior imaging
quality to CDUS and PDUS in demonstrating the
Color Doppler Ultrasound in Chest Medicine
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Fig. 10. (A) Traditional color Doppler ultrasound only shows pulmonary venous flow within the lesion. (B) Power Doppler ultra-
sound demonstrates the vessels within the lesion more clearly.
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Fig. 11. (A) Grayscale ultrasound (US) shows a hypoechoic lesion. (B) Tissue harmonic imaging also discloses a hypoechoic lesion.
(C) Color Doppler ultrasound shows the vessel signals with a blooming effect apparent within the lesion. (D) Power Doppler US
also detects the vessel signals with a prominent blooming effect. (E) Dynamic flow US illustrates the vessel signals without the
blooming effect.
vessel signals of thoracic lesions, with less blooming
effect and color noise. Larger studies are necessary
in the future to confirm our results.
Conclusion
Chest US examination and US-guided needle biopsy
have become useful diagnostic tools in clinical prac-
tice. The application of CDUS further extends the
potential function, clinical utility, and uses in research
of US in chest medicine. CDUS renders the US ex-
amination safer and more confident and prevents
possible injury to great vessels. The development of
PDUS (US angiography) improves the illustration of
vessel signals without angle limitation, and newly
developed DFUS exhibits superior imaging quality
with reduced color noise and blooming effect. The
broad applications of CDUS in thoracic diseases have
made CDUS a clinically powerful and necessary im-
aging modality, especially in guiding transthoracic
percutaneous needle biopsy of thoracic lesions. We
believe that CDUS will be widely applied in chest
medicine in the future.
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